Arch Therapeutics to Initiate Clinical Trial of AC5 in Europe December 16, 2015 The device is designed to control bleeding and fluid loss to help provide faster and safer surgical and interventional care. Read More
Arsenal Medical Secures $14M to Support ResQFoam Development December 14, 2015 ResQFoam works to stop massive blood loss in patients with severe internal bleeding within the abdomen. Read More
Avita Scores FDA EAP Designation for ReCell December 14, 2015 The device enables clinicians to rapidly regenerate healthy skin. Read More
Medtronic to Open Ireland Facility December 14, 2015 The facility will manufacture the company’s IN.PACT Admiral drug-coated balloon for the treatment of peripheral artery disease. Read More
St. Jude Medical Reports Positive Results for Axium Neurostimulator System December 14, 2015 The system showed superiority over traditional spinal cord stimulation in treating complex regional pain syndrome. Read More
Philips, Sensory Partner to Develop Speech Recognition Suite December 10, 2015 The companies will use Sensory’s TrulyHandsfree and TrulyNatural technnologies and Philips BeClear Speech Enhancement algorithms. Read More
MicroTransponder Closes $5.5 Million in Financing December 10, 2015 The funding will support the company’s stroke and tinnitus therapy in Europe in 2016. Read More
J&J, Verily Form Independent Surgical Company December 10, 2015 The company will develop robotic-assisted technologies for surgery. Read More
Mitralign Enrolls First Patient in Study of Trialign System December 4, 2015 The system is designed for the treatment of tricuspid regurgitation. Read More
Mount Sinai Medical Initiates Clinical Study of MyoVista December 4, 2015 Heart Test Laboratories’ device is designed for the early detection of heart disease. Read More
FDA Conditionally Clears InVivo’s Probable Benefit Study December 3, 2015 The approval is conditional upon what the company calls a minor change to the informed consent form already submitted to the FDA. Read More
StimRelieve Receives IDE Approval to Launch Trial of Halo CFNS System December 2, 2015 The system is a small, implantable device for the treatment of refractory craniofacial neuropathic pain. Read More